NCT01967251View on ClinicalTrials.gov

Efficacy, Safety and Dose-response of Udenafil in Patients With Benign Prostatic Hyperplasia and Erectile Dysfunction

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

September 30, 2015

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Erectile DysfunctionBenign Prostatic Hyperplasia
Interventions
DRUG

Udenafil

Udenafil tablets

DRUG

Placebo

Udenafil placebo-matching tablets

Trial Locations (8)

Unknown

Chihuahua City

Guadalajara

Mexico City

Morelia

Cuernavaca

Monterrey

Cholula

México

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT01967251 - Efficacy, Safety and Dose-response of Udenafil in Patients With Benign Prostatic Hyperplasia and Erectile Dysfunction | Biotech Hunter | Biotech Hunter